Alyeska Investment Group’s Surrozen SRZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$297K Hold
10,188
﹤0.01% 597
2025
Q4
$230K Hold
10,188
﹤0.01% 572
2025
Q3
$131K Hold
10,188
﹤0.01% 578
2025
Q2
$91.1K Hold
10,188
﹤0.01% 541
2025
Q1
$119K Hold
10,188
﹤0.01% 491
2024
Q4
$146K Sell
10,188
-10,188
-50% -$108K ﹤0.01% 536
2024
Q3
$244K Hold
20,376
﹤0.01% 501
2024
Q2
$223K Hold
20,376
﹤0.01% 529
2024
Q1
$320K Hold
20,376
﹤0.01% 438
2023
Q4
$192K Sell
20,376
-1
-0% -$7 ﹤0.01% 478
2023
Q3
$150K Buy
+20,377
New +$194K ﹤0.01% 464
2023
Q2
Sell
-20,377
Closed -$184K 624
2023
Q1
$184K Hold
20,377
﹤0.01% 432
2022
Q4
$178K Hold
20,377
﹤0.01% 398
2022
Q3
$617K Hold
20,377
0.01% 352
2022
Q2
$917K Hold
20,377
0.01% 501
2022
Q1
$920K Sell
20,377
-6,072
-23% -$300K 0.01% 525
2021
Q4
$2.56M Sell
26,449
-6,884
-21% -$781K 0.03% 400
2021
Q3
$2.96M Buy
33,333
+16,666
+100% +$2.35M 0.04% 427
2021
Q2
$2.48M Hold
16,667
0.03% 474
2021
Q1
$2.4M Buy
+16,667
New +$2.54M 0.03% 441

Other funds holding SRZN

Alyeska Investment Group's SRZN Position: Q1 2026 in Review

Alyeska Investment Group held its Surrozen (SRZN) position steady in Q1 2026 at 10,188 shares worth $297K. The position accounts for ﹤0.01% of the portfolio, ranked #597.

Alyeska Investment Group first reported a position in SRZN in Q1 2021 and has held it in 20 quarters since. The position peaked at $2.96M in Q3 2021. 59 funds tracked by Wall St. Rank hold SRZN as of Q1 2026.

  • Alyeska Investment Group held 10,188 shares of Surrozen worth $297K as of Q1 2026.
  • Alyeska Investment Group left its Surrozen share count unchanged in Q1 2026.
  • Surrozen made up ﹤0.01% of Alyeska Investment Group's portfolio in Q1 2026, its #597 holding.
  • Alyeska Investment Group first reported a position in Surrozen in Q1 2021 and has held it in 20 quarters since.
  • Alyeska Investment Group's Surrozen position peaked at $2.96M in Q3 2021.
  • 59 funds tracked by Wall St. Rank held Surrozen as of Q1 2026.

Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.